Abstract
Amrinone, a new cardiotonic drug, has received attention as a better therapeutic agent than the cardiac glycosides in the treatment of congestive heart failure. In this study, the effects of amrinone on isolated rat uterus and its probable mechanism of action were investigated. At two different concentrations (0.1 and 0.5 mM) the inhibitory effects of amrinone on the spontaneous contractions of rat uterus were noted. In addition, amrinone (0.5 mM) was found to inhibit the tonic contractions induced by potassium sulphate (K2SO4)-Ringer solution (91.74%) and calcium chloride (CaCl2) (93.04%). These inhibitory effects were compared with regulators of the phosphodiesterase enzyme (PDE). It was concluded that amrinone could behave as a calcium antagonist and PDE inhibitor.
Similar content being viewed by others
References
Ahn HS, Eardly D, Watkins R, Prioli N (1986) Effects of several cardiotonic drugs on cardiac cyclic AMP metabolism. Biochem Pharmacol 35: 1113–1121
Ally AI, Horrobin DF, Manku MS, Morgan RO, Karmazyn M, Karmali RA, Cunnane SC (1978) Dantrolene blocks intracellular calcium release in smooth muscle: competitive antagonism of thromboxane A2 Can J Physiol Pharmacol 56: 520–523
Alousi AA (1979) The inotropic efficacy and safety of amrinone in the presence of other cardiovascular drugs in dogs. Circulation 59: 11–16
Alousi AA, Farah AE (1978) Cardiotonic activity of amrinone (Win 40680): 5-amino-(3,4′-bipyridin)-6(1H)-one. Fed Proc Fed Am Soc Exp Biol 37: 914–918
Alousi AA, Helstrosky A (1980) Amrinone: a positive inotropic agent with a direct vasodilatory activity in the canine isolated perfused hind limb preparation. Fed Proc Fed Am Soc Exp Biol 39: 855
Alousi AA, Farah AE, Lesher GY, Opalka CJ (1979) Cardiotonic activity of amrinone-Win 30680 (5-amino-(3,4′-bipyridin)-6 (1H)-one. Circ Res 45: 666–667
Amer MS, Kreighbaum WE (1975) Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure-activity relationships and possible role in drug development. J Pharmacol Sci 64: 1–37
Andersson KE, Bengtsson B (1979) Effects of α-adrenoreceptor agonists on electrical and mechanical activity of the myometrium. Acta Pharmacol Toxicol 44: 64–75
Botinelli R, Cappelli V, Mormer SE, Reggiani C (1993) Effects of amrinone on shortening velocity and force development in skinned skeletal muscle fibres. J Muscle Res Cell Motil 14: 110–120
Bryson SE, Rodger IW (1987) Effects of phosphodiesterase inhibitors on normal and chemically-skinned isolated airway smooth muscle. Br J Pharmacol 92: 673–681
Calixto JB, Loch S (1985) Ketamine inhibition of calcium-induced contractions in depolarized rat uterus: a comparison with other calcium antagonists. Br J Pharmacol 85: 189–195
Carpendo F, Floreani M, Cargnelli G (1984) Competetive inhibition of phosphodiesterase activity by amrinone: its implication in the cardiac effect of the drug. Pharmacol Res Commun 16: 969–977
Dorigo P, Marango I (1986) Interaction of amrinone with endogenous adenosine in guineapig atria. Br J Pharmacol 87: 623–629
Dorigo P, Gaion RM, Giacometti A, Ceroni G, Marango I (1987) The role of calcium in amrinone action on intestinal smooth muscle. Pharmacol Res Commun 19: 29–40
Dorigo P, Gaion RM, Giacometti A, Ceroni G, Marango I (1987) Possible role of adenosine in the relaxant effect of amrinone on guinea-pig ileum. J Auton Pharmacol 7: 53–60
Eizing S, Pierpont ME (1981) Acute effects of amrinone (5-amino-(3,4′-bipyridin)-6(1H)-one) on systemic blood flow distribution. Am J Cardiol 47: 491
Endoh M, Yamashita S, Taira N (1982) Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther 221: 775–783
Farah AE, Alousi AA (1978) New cardiotonic agents: a search for digitalis substitute. Life Sci 22: 1139–1148
Fishburne JI, Dormer KJ, Payne GG, Gill PS, Ashrafzadeh AR, Rossavic IK (1988) Effects of amrinone and dopamine on uterine blood flow and vascular responses in the gravid baboon. Am J Obstet Gynecol 158: 829–837
Gaide MS, Baker SP, Ezrin AM (1980) Characterization of the inotropic and biochemical properties of amrinone: a novel cardiotonic agent Am J Cardiol 45: 412
Himmel HM, Schappert T, Ravens U (1991) Combined effects of volatile anesthetics and phosphodiesterase inhibitors on contractile performance in guinea-pig hearts. Anesth Analg 73: 76–82
Hoffman BF, Bigger JT (1990) Digitalis and allied cardiac glycosides. In: Gliman AG (ed) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 836–837
Honerjager P, Nawrath H (1992) Pharmacology of bipyridine phosphodiesterase III inhibitors. Eur J Anaesthiol 5: 7–14
Katzung BG, Parmley WW (1989) Cardiac glycosides and other drugs used in congestive heart failure. In: Katzung BG (ed) Basis and clinical pharmacology, 4th edn. Prentice-Hall, Conn, p 158
Kayaalp SO (1992) Rasyonel Tedavi Yonunden Tbbi Farmakoloji, 6th edn. Feryal Press, Ankara, pp 1276–1309
Kroeger EA, Marshall JM (1974) Beta adrenergic effects on rat myometrium: role of cyclic AMP. Am J Physiol 226: 1298–1303
Levine SD, Jacoby M, Satriona JA, Schlondorff D (1980) The effects of amrinone on transport and cyclic AMP metabolism in toad urinary bladder. J Pharmacol Exp Ther 21: 220–224
Malecot CO, Katzung BG (1984) Amrinone effects electromechanical coupling and depolarization-induced automatically in ventricular muscle of guinea-pigs and ferrets. J Pharmacol Exp Ther 232: 10–19
Marshall J, Kroeger EA (1973) Adrenergic influences on uterine smooth muscle. Philos Trans R Soc Lond Biol 265: 135–148
Meisheri KD, Palmer RF, Breemen CV (1980) The effects of amrinone on contractility, Ca2+ uptake and cAMP in smooth muscle. Eur J Pharmacol 61: 159–165
Morgan JP, Lee NKM, Blinks JR (1980) Mechanism of inotropic action of amrinone: unusual pattern of Ca2+ transients as detected with aequorin. Fed Proc Fed Am Soc Exp Biol 39: 854
Muset PP, Parellada PP, Esteve JM (1972) Biochemical and pharmacological aspects of imidazole, JIMS, Barcelona, pp 13–105
Rending SV, Amsterdam EA (1984) Positive inotropic action of amrinone: effect of elevated external Ca2+. J Cardiovasc Pharmacol 6: 293–299
Rodger IW (1986) Calcium ions and contraction of airways smooth muscle. In: Kay AB (ed) Asthma; clinical pharmacology and therapeutic progress. Blackwell, Oxford, pp 114–127
Rosenthal JE, Ferrier GR (1981) Inotropic and electrophysiologic effects of amrinone in untreated and digitalized ventricular tissues. J Pharmacol Exp Ther 22: 188–195
Singh M, Sharma PL (1980) Effect of imidazole on oxytocin-and acetylcholine-induced responses in isolated rat uterus: with observations on its mechanism of action. Arch Int Pharmacodyn Ther 246: 295–303
Singh M, Sharma PL (1985) Effects of cyclic nucleotide phosphodiesterase regulators on isolated rat uterus: with observations on their mechanism of action. Arch Int Pharmacodyn Ther 273: 180–195
Stice SL, Ford SP, Rosazza JP, Van Orden DE (1987) Role of 4-hydroxylated estradiol in reducing Ca2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. Biol Reprod 36: 361–368
Stone TW, Paton DM (1988) Actions of amrinone and milrinone on the guinea-pig ileum. J Pharm Pharmacol 40: 521–523
Van Breemen C (1977) Calcium requirement for activation of intact aortic smooth muscle. J Physiol (Lond) 272: 317–329
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kesim, Y., Celik, S. & Banoglu, N. The inhibitory effects of amrinone on isolated rat uterus. Res. Exp. Med. 194, 329–338 (1994). https://doi.org/10.1007/BF02576395
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02576395